FatBlaster Max (Cancelled from the ARTG under paragraphs 30(1)(e), 30(1)(g) and 30(2)(c) of the Act)

As it appeared to the Secretary that the medicine's label contained an indication that was not proposed to be accepted in relation to the inclusion of the medicine in the Register, the certification made under s.26A(2)(fba) of the Act was incorrect.It appeared to the Secretary that a statement made in, or in connection with, the application for listing of the goods was false or misleading in a material particular.The sponsor failed to comply with a condition of listing under s.28(5)(ab) of the Act (that the goods will not be advertised for an indication other than those accepted in the Register).